This inventor holds 11 USPTO granted patents and 17 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: The J. David Gladstone Institutes, University of California, Deutsches Krebsforschungszentrum. Active years: 2009-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- San Francisco, CA (US) (2009 - 2014)
- Mill Valley, CA (US) (2013 - 2023)
Company Filing History:
8 out of 91 
3 out of 16,048 
1 out of 159 
Years Active: 2009-2025
Title: The Innovative Contributions of Melanie Ott in Biotechnology
Introduction
Melanie Ott, based in San Francisco, CA, is a prominent figure in the field of biotechnology, with a notable portfolio of 11 patents. Her work primarily focuses on developing innovative methods for detecting and treating viral infections, specifically HIV and HCV.
Latest Patents
Among her latest patents, one involves the use of the CRISPR-Cas13a enzyme to detect and quantify HIV or HCV RNA in samples. This groundbreaking method allows for precise diagnosis of infections, quantification of viral load, and identification of various viral splice variants, subtypes, or mutations. Additionally, she has developed compositions and methods aimed at reactivating latent immunodeficiency virus and reducing transcription in HIV-infected cells, offering new avenues for treating such infections.
Career Highlights
Melanie has been associated with esteemed institutions such as the J. David Gladstone Institutes and the University of California, where she has significantly contributed to research and development projects targeting viral infections. Her innovative approaches have positioned her as a leader in her field, garnering attention from both the academic and medical communities.
Collaborations
Throughout her career, Melanie has collaborated with notable professionals including Eric M. Verdin and Daniela Boehm, which has further enhanced her research capabilities and led to impactful scientific advancements. These collaborations not only underscore her expertise but also her commitment to solving critical health challenges.
Conclusion
Melanie Ott's contributions to biotechnology through her patents and collaborations highlight her innovative spirit and dedication to improving methods for diagnosing and treating viral infections. Her work represents a significant advancement in the ongoing battle against HIV and HCV, making her an influential inventor in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile